Nike, DJT Rise; Corcept Falls

Stock Movers

On this episode of stock movers:

  • Nike (NKE) shares rose on Wednesday after CEO Elliott Hill reported the purchase of about $1 million in shares.
  • Corcept (CORT) shares fell after US regulators rejected the company’s drug to treat a form of high blood pressure.
  • The Food and Drug Administration “could not arrive at a favorable benefit-risk assessment” for the company’s drug, relacorilant, without more evidence of its effectiveness, the Redwood City, California-based company said in a statement Wednesday. 
  • Trump Media and Technology Group (DJT) shares rose on news the company, which operates President Donald Trump’s Truth Social platform, plans to issue a new cryptocurrency, which will be distributed among its shareholders.

See omnystudio.com/listener for privacy information.

2025-12-31 4 min Transcript

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

Open the Transcript tab to load the transcript.

Chapters

No chapters available.